Registration is now open for the Rare Disease Leadership Interactive Webinar on Tuesday, March 23. Click here to register now.
With feedback from the community, RARE on the Road 2021 will consist of one interactive webinar, open to all who wish to attend, regardless of their geographic location, and three virtual, state-specific meetings focusing on issues and resources relevant to residents in Nevada, Florida, and Illinois.
2021 RARE On The Road Dates:*
March 23, 2021 (11:00am-1:30pm ET): A Rare Disease Leadership Interactive Webinar
May 4, 2021: Virtual State-Specific Training and Networking Event | Nevada
May 11, 2021: Virtual State-Specific Training and Networking Event | Florida
May 18, 2021: Virtual State-Specific Training and Networking Event | Illinois
*Out of an abundance of caution regarding COVID-19, The EveryLife Foundation for Rare Diseases and Global Genes have made the decision to transition our 2021 RARE on the Road State-Specific Training and Networking events from in-person to virtual. While we may not be able to convene in person, our commitment to facilitating interactive and meaningful experiences remains.
Thank you to our 2021 RARE on the Road sponsors.
The EveryLife Foundation for Rare Diseases is a 501(c)(3) nonprofit, nonpartisan organization dedicated to empowering the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments and cures. We do not speak for patients. We provide the training, education, resources and opportunities to make their voices heard. By activating the patient advocate, we can change public policy and save lives.
About Global Genes
At Global Genes®, we believe that together we can do more to tackle the challenges of rare disease. We educate, equip, and empower the global community with tools and resources to influence change. We connect rare disease patients, advocates and rare disease experts to help eliminate the challenges of rare disease.